This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Seminars in Immunopathology Open Access 29 September 2022
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Singhal, S. et al. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer. Sci. Transl. Med. 11, 11–479 (2019).
Vanpouille-Box, C. & Formenti, S. C. Dual transforming growth factor-beta and programmed death-1 blockade: a strategy for immune-excluded tumors? Trends Immunol. 39, 435–437 (2018).
Martinenaite, E. et al. Frequent spontaneous adaptive immune responses towards arginase. Oncoimmunology 7, e1404215 (2017).
Keilholz, U. et al. Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J. Immunother. 25, 97–138 (2002).
Andersen, M. H. The balance players of the adaptive immune system. Cancer Res. 78, 1379–1382 (2018).
Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887–904 (2018).
Yu, W. et al. Clonal deletion prunes but does not eliminate self-specific alphabeta CD8(+) T lymphocytes. Immunity 19;42, 929–941 (2015).
Sorensen, R. B. et al. Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators. Blood 117, 2200–2210 (2011).
Munir, S. et al. HLA-restricted cytotoxic T cells that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients. Cancer Res. 73, 1674–1776 (2013).
Andersen, M. H. Immune regulation by self-recognition: novel possibilities for anticancer immunotherapy. J. Natl. Cancer Inst. 107, 154 (2015).
About this article
Cite this article
Martinenaite, E., Ahmad, S.M., Svane, I.M. et al. Peripheral memory T cells specific for Arginase-1. Cell Mol Immunol 16, 718–719 (2019). https://doi.org/10.1038/s41423-019-0231-3
This article is cited by
Seminars in Immunopathology (2023)
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope
Cancer Immunology, Immunotherapy (2019)